Pioneering Pharmaceutical Advance Targets Alzheimer’s Pre-Symptomatic Neuroinflammation
A novel small-molecule therapeutic, developed through rigorous scientific inquiry at Northwestern University, is demonstrating significant potential as an early intervention strategy for Alzheimer’s disease,...
